GILEAD SCIENCES, INC. logo

GILEAD SCIENCES, INC.

Public Company

GILEAD SCIENCES, INC. is a Public Company based in Foster City, CA led by Daniel O'Day, managing $1.8B across 9 long positions as of Q3 2025 with 68% Healthcare concentration, with only 9 positions, and 32% allocation to GLPG.

CEODaniel O'Day
Portfolio Value
$1.8B
Positions
9
Top Holding
GLPG at 32.31%
Last Reported
Q3 2025
Address333 Lakeside Dr, Foster City, CA, 94404

Top Holdings

Largest long holdings in GILEAD SCIENCES, INC.'s portfolio (100% of total portfolio)

See all holdings
HoldingSectorPositionWeightTradedOwnership
1
GLPG
Unknown
Unknown
$578.7M
32.31%
16.7M shares
Biotechnology
Healthcare
$551.8M
30.80%
12.12%
6.7M shares
Biotechnology
Healthcare
$427.4M
23.86%
29.53%
31.4M shares
Biotechnology
Healthcare
$115.3M
6.44%
+$58.8M
Bought
58.72%
4.5M shares
Biotechnology
Healthcare
$42.6M
2.38%
0.60%
452.5K shares
Biotechnology
Healthcare
$40.8M
2.28%
4.36%
4.9M shares
Biotechnology
Healthcare
$24.8M
1.38%
9.54%
4.1M shares
Biotechnology
Healthcare
$7.7M
0.43%
17.57%
9.1M shares
Biotechnology
Healthcare
$2.4M
0.13%
12.84%
5.3M shares

Changes

Portfolio activity, position movements, and quarter-over-quarter changes in GILEAD SCIENCES, INC.'s latest filing

See all changes
Market Value
$1.8B
Prior: $1.3B
Q/Q Change
+39.94%
+$511.3M
Net Flows % of MV
+3.0%
Turnover Ratio
1.78%
New Purchases
0 stocks
-
Added To
1 stocks
+$58.8M
Sold Out Of
5 stocks
$5.1M
Reduced Holdings
0 stocks
--

Increased Positions

PositionShares Δ
+103.91%

Decreased Positions

PositionShares Δ
Sold
Sold
Sold
Sold
Sold

Analytics

Portfolio insights and performance metrics for GILEAD SCIENCES, INC.

View analytics

Sector Allocation

Healthcare: 67.70%Healthcare
Healthcare
67.70%

Market Cap Distribution

Mid Cap ($2B - $10B): 33.18%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 26.13%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 7.82%Nano Cap (< $50M): 0.56%N/A (ETF or Unknown): 32.31%N/A (ETF or Unknown)
Mid Cap ($2B - $10B)
33.18%
Small Cap ($300M - $2B)
26.13%
Micro Cap ($50M - $300M)
7.82%
Nano Cap (< $50M)
0.56%
N/A (ETF or Unknown)
32.31%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.